Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line
Citations
254 citations
218 citations
177 citations
80 citations
80 citations
Additional excerpts
...mutations [6,7,8,10,11,12,13], suggesting that other unknown...
[...]
References
1,548 citations
1,349 citations
"Evidence for efficient phosphorylat..." refers background in this paper
...Background The epidermal growth factor receptor (EGFR) is a prototypical member of the ErbB family of tyrosine kinases and plays an important role in the pathogenesis of different tumors; therefore, therapies directed at inhibiting EGFR function have potential as anticancer treatments [1,2]....
[...]
1,051 citations
"Evidence for efficient phosphorylat..." refers background in this paper
...It was also shown that nuclear EGFR levels were increased on treatment with EGF and that the EGFR which accumulated in the nucleus was highly tyrosine phosphorylated; it was further demonstrated that nuclear EGFR acts as a transcription factor for activating gene expression of cyclin D1, a well-known cell growth-promoting factor [26]....
[...]
...In fact, it has recently been reported that nuclear localization of EGFR is detected in the highly proliferating state of human cancer tissues in vivo and human breast cancer cell lines in vitro, supporting the close correlation between nuclear EGFR and tumor tissues with high proliferation [25-27]....
[...]
838 citations
"Evidence for efficient phosphorylat..." refers background in this paper
...Gefitinib (Iressa, ZD1839) is a selective EGFR tyrosine kinase inhibitor that functions by competing with ATP for binding to the tyrosine kinase domain of the receptor, and it blocks the signal transduction pathways implicated in the proliferation and survival of cancer cells [6-9]....
[...]
787 citations
"Evidence for efficient phosphorylat..." refers background in this paper
...It has exhibited significant antitumor activity against a broad range of mouse tumor xenograft models in vivo [10] and tumor cell lines in vitro [11]....
[...]